Effects of Dairy Products on Crohn's Disease Symptoms Are Influenced by Fat Content and Disease Location but not Lactose Content or Disease Activity Status in a New Zealand Population

Journal of the American Dietetic Association

Volumn 111, Issue 8, 2011, Pages 1165-1172

  Nolan Clark, Deborah ^a   Tapsell, Linda C ^a   Hu, Rong ^b   Han, Dug Yeo ^b   Ferguson, Lynnette R ^b  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOSE;

ARTICLE; CALCIUM INTAKE; CHI SQUARE DISTRIBUTION; COLON; CONFIDENCE INTERVAL; CROHN DISEASE; DAIRY PRODUCT; FAT INTAKE; FEMALE; HEALTH STATUS; HOSPITALIZATION; HUMAN; ILEUM; MALE; MIDDLE AGED; NEW ZEALAND; PATHOLOGY; RISK; SELF DISCLOSURE;

CALCIUM, DIETARY; CHI-SQUARE DISTRIBUTION; COLON; CONFIDENCE INTERVALS; CROHN DISEASE; DAIRY PRODUCTS; DIETARY FATS; FEMALE; HEALTH STATUS; HUMANS; ILEUM; LACTOSE; MALE; MIDDLE AGED; NEW ZEALAND; ODDS RATIO; SELF DISCLOSURE; SEVERITY OF ILLNESS INDEX;

EID: 79960785372     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jada.2011.05.004     Document Type: Article

References (30)

1. Veloso F.T., Ferreira J.T., Barros L., Almeida S. Clinical outcome of Crohn's disease: Analysis according to the Vienna classification and clinical activity. Inflamm Bowel Dis 2001, 7:306-313.
2. Gearry R.B., Richardson A., Frampton C.M.A., Collett J.A., Burt M.J., Chapman B.A., Barclay M.L. High incidence of Crohn's disease in Canterbury, New Zealand: Results of an epidemiologic study. Inflamm Bowel Dis 2006, 12:936-943.
3. Barrett J.S., Irving P.M., Shephard S.J., Muir J.G., Gibson P.R. Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol Ther 2009, 30:165-174.
4. Knoflach P., Park B.H., Cunningham R., Weiser M.M., Albini B. Serum antibodies to cow's milk proteins in ulcerative colitis and Crohn's disease. Gastroenterology 1987, 92:429-485.
5. von Tirpitz C., Kohn C., Steinkamp M., Geerling I., Maier V., Möller P., Adler G., Reinshagen M. Lactose intolerance in active Crohn's disease clinical value of duodenal lactase analysis. J Clin Gastroenterol 2002, 34:49-53.
6. Vesa T.H., Marteau P., Korpela R. Lactose intolerance. J Am Coll Nutr 2000, 19(suppl):165S-175S.
7. Triggs C.M., Munday K., Hu R., Fraser A.G., Gearry R.B., Barclay M.L., Ferguson L.R. Dietary factors in chronic inflammation: Food tolerances and intolerances of a New Zealand Caucasian Crohn's disease population. Mutat Res 2010, 690:123-138.
8. Satsangi J., Silverberg M.S., Vermeire S., Colombel J.F. The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications. Gut 2006, 55:749-753.
9. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D.R., Bernstein C.N., Brant S.R., Caprilli R., Colombel J.F., Gasche C., Geboes K., Jewell D.P., Karban A., Loftus E.V., Pena A.S., Riddell R.H., Sachar D.B., Schreiber S., Steinhart A.H., Targan S.R., Vermeire S., Warren B.F. Towards an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(suppl A):5A-36A.
10. Héla S., Nihel M., Faten L., Monia F., Boubaker J., Azza F., Slaheddine S. Osteoporosis and Crohn's disease. Joint Bone Spine 2005, 72:403-407.
11. Yang Y.X., Lichtenstein G.R. Corticosteroids in Crohn's disease. Am J Gastroenterol 2002, 97:803-823.
12. Ghosh S., Cowen S., Hannan W.J., Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994, 107:1031-1039.
13. Manolagas S.C., Jilka R.L. Bone marrow, cytokines, and bone remodeling-Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995, 332:305-311.
14. Russel D.G., Parnell W.R., Wilson N.C., Faed J., Ferguson E., Herbison P., Horwath C., Nye T., Reid P., Walker R., Wilson B. NZ Food: NZ People. Key Results of the 1997 National Nutrition Survey 1999, Ministry of Health, Wellington, New Zealand.
15. Abitbol V., Mary J.Y., Roux C., Soulé J.C., Belaiche J., Dupas J.L., Gendre J.P., Lerebours E., Chaussade S. Osteoporosis in inflammatory bowel disease: Effect of calcium and vitamin D with or without fluoride. Aliment Pharmacol Ther 2002, 16:919-927.
16. Baran D., Sorensen A., Grimes J., Lew R., Karellas A., Johnson B., Roche J. Dietary modification with dairy products for preventing vertebral bone loss in premenopausal women: A three-year prospective study. J Clin Endocrinol Metab 1990, 70:264-270.
17. Riitta K. Symptoms of lactose intolerance. Scand J Nutr 2001, 45:171-173.
18. Joos S., Rosemann T., Szecsenyi J., Hahn E.G., Willich S.N., Brinkhaus B. Use of complementary and alternative medicine in Germany-A survey of patients with inflammatory bowel disease. BMC Complement Altern Med 2006, 6:19.
19. Jamieson A.E., Fletcher P.C., Schneider M.A. Seeking control through the determination of diet: A qualitative investigation of women with irritable bowel syndrome and inflammatory bowel disease. Clin Nurse Spec 2007, 21:152-160.
20. O'Sullivan M., O'Morain C. Nutrition in inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2006, 20:561-573.
21. Gentilcore D., Chaikomin R., Jones K.L., Russo A., Feinle-Bisset C., Wishart J.M., Rayner C.K., Horowitz M. Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes. J Clin Endocrinol Metab 2006, 91:2062-2067.
22. Annese V., Bassotti G., Napolitano G., Usai P., Andriulli A., Vantrappen G. Gastrointestinal motility disorders in patients with inactive Crohn's disease. Scand J Gastroenterol 1997, 32:1107-1117.
23. Chen J.D.Z., Zhiyue L., Pan J., McCallum R.W. Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis. Dig Dis Sci 1996, 41:1538-1545.
24. Bassaganya-Riera J., Hontecillas R., Beitz D.C. Colonic anti-inflammatory mechanisms of conjugated linoleic acid. Clin Nutr 2002, 21:451-459.
25. Lorea Baroja M., Kirjavainen P.V., Hekmat S., Reid G. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin Exp Immunol 2007, 149:470-479.
26. Daddaoua A., Puerta V., Requena P., Martínez-Férez A., Guadix E., Sánchez de Medina F., Zarzuelo A., Suárez M.D., Boza J.J., Martínez-Augustin O. Goat milk oligosaccharides are anti-inflammatory in rats with hapten-induced colitis. J Nutr 2006, 136:672-676.
27. Russ A., Barnett M., McNabb W., Andersen R., Reynolds G., Roy N. Post-weaning effects of milk and milk components on the intestinal mucosa in inflammation. Mutat Res 2010, 690:64-70.
28. Park Y.W., Juárez M., Ramos M., Haenlein G.F.W. Physico-chemical characteristics of goat and sheep milk. Small Rumin Res 2007, 68:88-113.
29. Adolfsson O., Meydani S.N., Russell R.M. Yogurt and gut function. Am J Clin Nutr 2004, 80:245-256.
30. Van Limbergen J., Wilson D.C., Satsangi J. The genetics of Crohn's disease. Annu Rev Genomics Hum Genet 2009, 10:89-116.